ZD6474, a co-inhibiter of VEGFR/EGFR and mTOR kinases, is also illustrated substantially higher anti-proliferative activity than either VEGFR inhibitor or EGFR inhibitor alone applied in cancers [18]. Here, KDR is linked to cancer.